Swiss cannabis market size: evidence and limitations
A defensible market size needs a clear sales scope, traceable sources and comparable periods. Unsubstantiated revenue and growth figures remain unresolved.
Key facts
- Retail revenue: Not established
- Annual growth: Not established
- Outlet count: Not established
Key takeaways
- Consumption frequency does not measure revenue. A survey percentage is not a financial market size.
- CBD products, medical uses and pilot trials need separate definitions before figures can be compared.
- Unresolved revenue and share fields indicate missing evidence, not a market without sales.
Interpretation
A precise figure may sound convincing, but traceable origins and a clear scope are what make it defensible. The former growth curve and fixed segment shares were removed because their evidence was not traceable here. This does not establish the actual value of the Swiss market. Future publications must first distinguish domestic sales from exports, sales stages and product categories. Every point then needs an original source covering the same scope. Even mathematically correct growth remains unsupported if its input values are unsupported. The table, downloads and structured data therefore reflect the same unresolved evidence.
Limitations
- No substantiated revenue time series for this overview. Missing values do not mean zero revenue.
- The MonAM source does not measure revenue.
- Product categories organise the table; they establish neither market shares nor the legal status of every product.
Data
| Product category | Substantiated revenue | Substantiated market share |
|---|---|---|
| Flowers | Not established | Not established |
| Oils | Not established | Not established |
| Vaping products | Not established | Not established |
| Hash and extracts | Not established | Not established |
Methodology
This page reviews the support for previously published market estimates; it does not supply a new revenue dataset. No traceable original evidence is available here for the former annual revenues, segment shares, growth rates or outlet counts. They are therefore no longer presented as measurements. The linked MonAM indicator documents a consumption survey; it is explicitly not evidence of CBD revenue. A defensible series would specify products, sales stage, domestic sales or exports, observation year and calculation. Adding wholesale and retail as separate final sales would count the same flows twice. The source review on 4 October 2026 is not a new observation year.
Sources
- FOPH / Obsan: cannabis use — definition and survey — BAG / Obsan
Related data & articles
Parent
Same category
- Swiss cannabis economy: employment and scenarios in the 2022 study — Market dataset
Related datasets
- Swiss cannabis pilot projects: reviewed project register — Dataset · Pilot projects
- Cannabis use in Switzerland: SHS prevalence 2022, ages 15–64 — Dataset · Consumption
- Swiss cannabis and hemp trade: evidence and limits — Dataset · Trade
- Swiss cannabis price index — illustrative model — Dataset · Prices
Matching knowledge hubs
- Cannabis statistics Switzerland — Knowledge hub
- CBD — The complete Switzerland hub — Knowledge hub
Articles
No substantiated revenue time series for this overview. Missing values do not mean zero revenue.